(Total Views: 472)
Posted On: 06/02/2020 12:18:44 PM
Post# of 145879
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: DuckDiggler #36219
Lung cancer is listed in the Phase 2 Cancer Trial.
https://www.cytodyn.com/newsroom/press-releas...nlimab-pro
Wishing the best for your Advisor's MiL.
https://www.cytodyn.com/newsroom/press-releas...nlimab-pro
Quote:
The Company can immediately initiate enrollment in this Phase 2 clinical trial for the treatment of approximately 22 different solid tumor cancers, including melanoma, brain-glioblastoma, throat, lung , stomach, colon carcinoma, breast, testicular, ovarian, uterine, pancreas, bladder, among other indications. The Company expects to receive preliminary results on each patient within 3 to 4 weeks after the initial treatment with leronlimab. The Company will continue to enroll patients in its metastatic breast cancer trials.
Wishing the best for your Advisor's MiL.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)